>>On the Market
Healthcare Professionals: Please visit the Aggrastat product website.
Medicure is currently developing a transdermal delivery formulation of its lead
AGGRASTAT (tirofiban HCl).
January 27, 2015
Medicure Announces Shares for Debt SettlementsRead more
January 9, 2015
Medicure Announces Issuance of Shares Under Previously Announced Shares for Debt Settlement Read more
December 18, 2014
Medicure Announces Change in Fiscal Year End and Provides One-Time Guidance on Quarterly Revenue Read more
Sign up to receive email updates such as Press Release nofications and other company news.